Top Industry Leaders in the Nanobiosensors in Healthcare Market
Latest Nanobiosensors in Healthcare Companies Update
Abbott (NYSE: ABT) Launched the FreeStyle Libre 3 system, a continuous glucose monitoring (CGM) system using nanobiosensors that eliminates the need for finger pricking for calibration.
Roche (OTCQX: RHHBY) Received FDA approval for their Elecsys IL-6 assay, a nanobiosensor-based test for rapid and accurate measurement of IL-6, a key inflammatory marker, in COVID-19 patients.
Bio-Techne (NASDAQ: BTECH) Launched their ExoPlex platform, a suite of nanobiosensor-based exosome isolation and analysis tools for early cancer detection and personalized medicine
Nano-Proprietary (OTCQB: NANP) Partnered with the University of California, San Diego to develop nanobiosensors for early detection of Alzheimer's disease.
Roche and AstraZeneca Partnered to develop and commercialize a novel nanobiosensor-based blood test for early-stage lung cancer detection.
MIT and Texas A&M University Collaborated to develop a microfluidic chip with built-in nanobiosensors for rapid and portable detection of infectious diseases.
List of Nanobiosensors in Healthcare Key Companies in the Market
- Abbott Point of Care Inc.
- Hoffman-LA Roche Ltd.
- Medtronic Inc.
- Nano-Proprietary Inc.
- Lifescan Inc.
- Illuminex Corporation
- Lifesensors Inc.
- ACON Laboratories Inc.
- Pharmaco-Kinesis Corporation
- Bayer Healthcare AG
- Bio-Rad Laboratories Inc.
- Biosensors International Pte. Ltd.
- Sysmex Corporation
